AlloSource Enters into Licensing Agreement with Keratec to Add Enhanced DBM Putty Product to Line-up
Published: Nov 05, 2007
CENTENNIAL, Colo.--(BUSINESS WIRE)--AlloSource, one of the nation’s largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, announced today that it has entered into a licensing agreement with Keratec Limited of New Zealand. Under the agreement, Keratec and AlloSource will jointly develop a next-generation DBM putty utilizing Keratec’s proprietary Keragraft technology. Keragraft is an optimal carrier in combination with DBM and initial studies demonstrate superior bone growth characteristics.